DNA ligase variants
Mutant bacteriophage DNA ligases that have increased tolerance to salt and/or heat is provided. Methods, compositions and kits that employ the same are also provided.
1. A DNA ligase, wherein the DNA ligase:
(i) has at least 90% sequence identity to SEQ ID NO:1; and
(ii) comprises one or more amino acid substitutions at the position corresponding to positions 142, 145, 155, 292, 318, 327, 358, 363 and 445 in SEQ ID NO:1;
wherein if the substitution is at a position corresponding to position 292, the amino acid substitution is not glycine and
wherein if the substitution is at a position corresponding to position 358, the amino acid substitution is not alanine or threonine.
2. The DNA ligase of claim 1 , wherein the ligase comprises a substitution at the position corresponding to position 358.
3. The DNA ligase of claim 2 , wherein the ligase comprises at least one additional substitution.
4. The DNA ligase of claim 2 , wherein the ligase comprises at least two additional substitutions.
5. The DNA ligase of claim 2 , wherein the at least one additional substitution is selected from a position corresponding positions to 12, 19, 23, 35, 41, 42, 43, 50, 63, 66, 71, 89, 99, 108, 119, 121, 127, 140, 142, 145, 149, 155, 175, 178, 192, 199, 210, 213, 270, 272, 275, 284, 288, 289, 290, 292, 293, 294, 295, 299, 301, 302, 306, 309, 310, 311, 312, 318, 323, 324, 327, 333, 339, 351, 353, 363, 375, 387, 393, 426, 427, 429, 439, 445, 446, 456, 461, 462, 466 and 476 in SEQ ID NO:1.
6. The DNA ligase of claim 1 , that has at least 95% sequence identity to SEQ ID NO:1.
7. The DNA ligase of claim 1 , further comprising one or more additional amino acid substitutions at a positions corresponding to positions 19, 63, 140, 142, 213, 292, 293, 299, 318, 327, 358, 445, 455, 461, 462 and 466 in SEQ ID NO:1.
8. The DNA ligase of claim 1 , further comprising one or more additional substitutions selected from Q19L, L63Q, S140P, D142S, G145K, F155Y, L213M, S292G, L293K, K299P, I318R, N327S A358K, A358G, L363Q L445V, L455V, A461I, I462K, E466I, and E466W, wherein the amino acid substitutions are at a positions corresponding to positions in SEQ ID NO:1.
9. The DNA ligase of claim 1 , wherein the ligase comprises two or more amino acid substitutions relative to SEQ ID NO: 1.
10. The DNA ligase of claim 8 , wherein the ligase comprises five or more amino acid substitutions relative to SEQ ID NO: 1.
11. The DNA ligase of claim 8 , wherein the ligase comprises ten or more amino acid substitutions relative to SEQ ID NO:1.
12. The DNA ligase of claim 1 , wherein the ligase is a fusion protein.
13. The DNA ligase of claim 1 , wherein, as a result of the one or more amino acid substitutions, the ligase has increased stability at 45° C., 50° C. and/or 55° C. relative to the T4 DNA ligase of SEQ ID NO:1.
14. The DNA ligase of claim 1 , wherein, as a result of the one or more amino acid substitutions, the ligase has increased activity in a buffer comprising NaCl or KCl relative to the T4 DNA ligase of SEQ ID NO:1.
15. The DNA ligase of claim 1 , wherein the ligase has increased activity in a buffer comprising 250 mM salt relative to the T4 DNA ligase of SEQ ID NO:1.
16. The DNA ligase of claim 1 , wherein the ligase has increased activity in a buffer comprising 300 mM, 400 mM and/or 500 mM salt relative to the T4 DNA ligase of SEQ ID NO:1.
17. A composition comprising:
a. the DNA ligase of claim 1 ; and
b. a buffering agent.
18. A kit comprising:
a. the DNA ligase of claim 1 ; and
b. a reaction buffer.
19. A method for ligating polynucleotides, comprising:
a. combining the DNA ligase of claim 1 with a first polynucleotide and a second polynucleotide to produce a reaction mix; and
b. incubating the reaction mix to permit the DNA ligase to ligate the 5′ end of the first polynucleotide to the 3′ end of the second polynucleotide.
20. The method of claim 19 , wherein the incubating is done at a temperature of at least 45° C.
21. The method of claim 19 , wherein the reaction mix comprises salt at a concentration of at least 20 mM.
22. The method of claim 19 , wherein the ends of the DNA in the ligation are selected from the group consisting of 5′ overhangs of any length, 3′ overhangs of any length, and blunt ends.